Skip to main content
. 2017 Mar 3;1(1):114–130. doi: 10.7150/ntno.18292

Fig 18.

Fig 18

(A) Tumor-associated activation of the nanoprobe. (B) Blood vessel staining (green) and the activated nanoprobe (red) in HT1080 tumor. (C) Western blotting analysis of MMP-2 in HT1080, MCF-7, and SW620 tumor. Reproduced with permission from 69.